• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ionis Pharmaceuticals - Articles and news items


GSK initiates Phase 1 study of IONIS-HBV-LRx; Ionis gets milestone payment

Industry news / 13 January 2016 / Victoria White

IONIS-HBV-LRx (previously referred to as ISIS-GSK6-LRx) is a drug Ionis is developing with GSK for the treatment of patients with hepatitis B virus…

huntington's disease

FDA grants Orphan Drug Designation to IONIS-HTTRx

Industry news / 5 January 2016 / Victoria White

IONIS-HTTRx is a Gen. 2.0+ antisense drug in development for the treatment of Huntington’s disease…


Isis Pharmaceuticals becomes Ionis Pharmaceuticals

Industry news / 18 December 2015 / Victoria White

Explaining his reasoning behind the company name change, Stanley Crooke, CEO of Ionis, told Forbes: “My underlying concern was that the name was a distraction”…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +